Wolters Kluwer Launches Trial Campaign for Lexicomp, Drug Information Resource to Support EBM Practices in Pharmacy Department

Lexicomp facilitates advancement of drug information while providing shared care guidelines with UpToDate

(December 9, 2020) – Wolters Kluwer announced the launch of a trial campaign for Lexicomp, a drug information resource to support evidence-based medicine (EBM) practices in the pharmacy department. During the trial period, customers will have free access to the global standard drug information resources encompassed in Lexicomp. Lexicomp, along with "UpToDate", the global leader for clinical decision support (CDS) resource which has nearly 30 years of experience, is at the core of Wolters Kluwer's Clinical Effectiveness solutions and will drive the advancement of drug information in the pharmacy department.

With the increased importance of reliable, high-quality, evidence-based medicine in the time of uncertainty such as the COVID-19 pandemic, there is a growing need for pharmacists to be involved more proactively in the clinical decision-making process. However, inconsistencies in the information used by multiple healthcare professionals can lead to delayed and inefficient decision-making as a care team, which can lead to issues such as variability in care (*1). Unwarranted care variation can happen at every decision point for every patient. That's why, today more than ever, expert, reliable, clinical decision support is desired.

Lexicomp allows customers to quickly access global-standard drug information, including topics such as medications and guidelines for often under-informed patients such as pediatric and neonatal patients, the elderly, pregnant and lactating women, condition-specific precautions such as renal and hepatic dysfunction, IV compatibility, patient education (up to 19 languages supported), and infectious diseases, to improve patient safety and the efficiency for healthcare professionals.

  • Target Product
    Drug Information Resource "Lexicomp"
  • Campaign Period
    We will take requests for trial from today through Wednesday, March 31, 2021
  • Eligible Customer
    Customer who belongs to a healthcare institute and wishes to conduct the trial as a pharmacy department or an organization
  • How to Apply
    Visit the registration page using the URL or QR code below and fill out and submit a form.
  • Campaign Terms and Conditions
    • The standard trial period is one month.
    • The use of Lexicomp shall be within the scope of our terms and conditions.
    • We may change, suspend, discontinue and terminate the campaign at any time without notice if we deem it necessary.

*1 Advisory Board points out that unwarranted care variation exists within most provider organizations, and represents a $20M‒$30M (per $1B in revenue) actionable savings opportunity for a typical organization. Source: Unwarranted Variations in Care: Origins and Approaches to Reduction, Advisory Board, May 2017.